Login

Samuel J Gagne

ORCID: 0000-0002-3432-296X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5109629399
Research Areas
  • Systemic Lupus Erythematosus Research
  • Eosinophilic Disorders and Syndromes
  • Vasculitis and related conditions
  • Renal Diseases and Glomerulopathies
  • Complement system in diseases

Children's Hospital of Pittsburgh
 2024

University of Pittsburgh
 2024

Nationwide Children's Hospital
 2023

 Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset ANCA‐Associated Vasculitis: An ARChiVe registry‐cohort study
OPENALEX - Publications 
Samuel J Gagne Vidya Sivaraman Else S. Bosman Brett Klamer Kimberly Morishita and 22 more Adam M. Huber Alvaro Orjuela B. Anne Eberhard Charlotte Myrup Dana Gerstbacher Dirk Foell Eslam Al‐Abadi Flora McErlane Kathryn Cook Linda Wagner‐Weiner Melissa E. Elder L. Nandini Moorthy Paul Dancey Rae S. M. Yeung Raju Khubchandani Samundeeswari Deepak Sirirat Charuvanij Stacey E. Tarvin Susan Shenoi Tamara Tanner Kelly L. Brown David A. Cabral

Objective Granulomatosis with polyangiitis (GPA) and microscopic (MPA) are chronic life‐threatening vasculitides requiring substantial immunotherapy. Adult trials identified rituximab (RTX) as an alternative to cyclophosphamide (CYC) for remission‐induction of GPA/MPA. Disease rarity has limited feasibility similar in pediatrics. We aim evaluate the relative efficacy toxicity CYC RTX childhood GPA/MPA through registry‐based comparative evaluation. Methods From A Registry Childhood Vasculitis...

10.1002/acr.25455 article EN cc-by-nc Arthritis Care & Research 2024-10-28
Coming Soon ...